Amid a surge in COVID-19 cases in Delhi, Chief Minister Arvind Kejriwal has directed authorities to increase the number of ICU beds in hospitals and take steps to contain the spread of the infection, Health Minister Satyendar Jain said on Thursday.
Interacting with reporters, he also said plasma therapy will continue to be used in Delhi as it is proving to be effective in people who are in stage one or two of COVID-19 treatment, but not in stage three or those on ventilators.
He told this to mediapersons when asked to respond about an Indian Council of Medical Research-funded study which has found that use of convalescent plasma therapy in coronavirus-infected patients does not help in reducing mortality or progression to severe COVID-19 stage.
The chief minister had on Wednesday held a review meeting with Jain, Chief Secretary Vijay Dev, senior officials and medical superintendents of Delhi government-run hospitals and asked them to take all possible steps to prevent the spread of virus.
"The meeting was held to assess the current situation of COVID-19 and medical superintendents of all hospitals were present in it. The main outcome of the meeting was that CM has directed authorities to increase the number of ICU beds (in hospitals)," Jain said.
Delhi reported 4,039 fresh COVID-19 cases on Wednesday, the highest single-day spike so far, as thetally breached the two lakh-mark in the city. On Wednesday, a record 54,517 tests were conducted by authorities in 24 hours, the health bulletin had said.
This was the first time since the outbreak of the pandemic, that over 4,000 cases were recorded in Delhi in a day. The previous highestsingle-day spike of 3,947 cases was recorded on June 23.
Twenty fatalities were recorded in the last 24 hours taking the death toll to 4,638, according to the bulletin issued on Wednesday.
"Delhi recorded highest spike in cases so far. But, it is also because we have gone aggressive on testing, with over 54,000 tests, highest ever in Delhi. And, we had set a target of 40,000 tests per day. So, we do not want to to leave any infected person in tracing," Jain told reporters.
Out target is to ensure "zero mortality" and treatment protocols have been standardised, he added.
The positivity rate on Wednesday was 7.4 per cent which is close to the corresponding figure at a national level (7.5 per cent), Jain said.
On the ICMR-funded study, which has not yet been peer-reviewed and has appeared on medRxiv, a pre-print server, the health minister asked whether the ICMRhas said it is wrong.
Plasma therapy has been in use for many decades for various diseases. As of now there is no standard treatment for COVID-19. And, patients in ICU, who are in first two stages, it is proving effective on them, he said.
"I myself am a COVID survivor and was administered plasma therapy, so I am telling," he said, adding, that roughly 1,000 patients have been administered the therapy in Delhi.
On the provision to getting tests done without any doctor's prescription, Jain said an AADHAAR card or any other identify proof will do. For RT-PCR, AADHAAR card will be required, he said.
Jain also held a meeting with medical directors and medical superintendents of all Delhi government hospitals on Wednesday to review the status of testing, the bulletin had said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)